Showing results (11-20 of 113) with videos related to
Sort By:
Pageof 12
Biochemical Pharmacology|December 13, 1996
Functional consequences of the phosphorylation of the gonadotropin receptorsM AscoliThe Journal of Biological Chemistry|November 10, 1978
Inhibition of the degradation of receptor-bound human choriogonadotropin by lysosomotropic agents, protease inhibitors, and metabolic inhibitorsM Ascoli, D PuettEndocrinology|November 1, 1976
Biotransformations of pituitary luteinizing hormone in serum and urine. I. Association with serum componentsM Ascoli, D PuettThe Journal of Biological Chemistry|December 25, 1984
Na+ modulates the affinity of the lutropin/choriogonadotropin receptorK Buettner, M AscoliProceedings of the National Academy of Sciences of the United States of America|January 1, 1978
Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cellsM Ascoli, D PuettMolecular Pharmacology|September 25, 1999
A dileucine-based motif in the C-terminal tail of the lutropin/choriogonadotropin receptor inhibits endocytosis of the agonist-receptor complexK Nakamura, M AscoliMolecular Endocrinology (Baltimore, Md.)|June 10, 2000
The C-terminal tail of the rat lutropin/choriogonadotropin (CG) receptor independently modulates human (h)CG-induced internalization of the cell surface receptor and the lysosomal targeting of the internalized hCG-receptor complexM Kishi, M AscoliEndocrinology|November 1, 1976
Biotransformations of pituitary luteinizing hormone in serum and urine. II. Evidence for reduced potency following urinary excretionM Ascoli, D PuettThe Journal of Biological Chemistry|August 1, 2000
Multiple distant amino acid residues present in the serpentine region of the follitropin receptor modulate the rate of agonist-induced internalizationH Kishi, M AscoliMolecular Endocrinology (Baltimore, Md.)|November 15, 2000
Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptorL Min, M AscoliPageof 12